Genital Herpes News and Research

RSS
Women using DMPA injection more likely to acquire HIV than women using NET-EN

Women using DMPA injection more likely to acquire HIV than women using NET-EN

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

Most U.S. adolescents lack antibodies that may help protect against genital herpes, says study

Most U.S. adolescents lack antibodies that may help protect against genital herpes, says study

Discovery paves way for development of new medicines to combat herpes infections

Discovery paves way for development of new medicines to combat herpes infections

Researchers potentially reached milestone in vaccine treatment for genital herpes

Researchers potentially reached milestone in vaccine treatment for genital herpes

Pain, itching associated with shingles may be due to virus causing "short circuit" in nerve cells

Pain, itching associated with shingles may be due to virus causing "short circuit" in nerve cells

Apoptosis can reactivate latent herpesviruses in dying cell

Apoptosis can reactivate latent herpesviruses in dying cell

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

NanoViricides submits letter of intent to file Orphan Drug Application with EMA for DengueCide

European Commission grants orphan drug designation for maribavir for treatment of CMV disease

European Commission grants orphan drug designation for maribavir for treatment of CMV disease

NanoViricides files Orphan Drug application with FDA for DengueCide

NanoViricides files Orphan Drug application with FDA for DengueCide

Scientists identify new class of immune cells that suppress genital herpes

Scientists identify new class of immune cells that suppress genital herpes

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

Viral protein hijacks cellular machinery and grabs the wheel

Viral protein hijacks cellular machinery and grabs the wheel

A new strategy to prevent herpes virus infections

A new strategy to prevent herpes virus infections

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides retires Series C Convertible Preferred Stock previously purchased by Seaside

NanoViricides to advance influenza drug candidate with completed $5M funding

NanoViricides to advance influenza drug candidate with completed $5M funding

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A